About Fibrogenesis & Tissue Repair

This page includes information about the aims and scope of Fibrogenesis & Tissue Repair, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

Fibrogenesis & Tissue Repair is an open access, peer-reviewed online journal featuring high-quality studies providing novel insights into the mechanisms, diagnosis and treatment of human diseases characterized by chronic wound healing and fibrogenesis.

Fibrogenesis & Tissue Repair focuses on the discovery and characterization of the mechanisms of fibrogenesis and tissue repair.

Fibrogenesis & Tissue Repair covers five major areas of fibroproliferative disorders: gastrointestinal and liver disease; renal disease; rheumatology and connective tissue disease; pulmonary disease and cardiovascular disease. Particular emphasis is given to studies leading to a significant advancement in the fields of genetic predisposition, diagnostic biomarkers and drug discovery. The journal will also publish important advancements in regenerative medicine and cell therapy related to fibroproliferative disease, and in the involvement of the stroma in cancerogenesis and tumor metastasis.

Fibrogenesis & Tissue Repair is the first journal dedicated to understanding, diagnosing and treating fibroproliferative diseases.

Fibrogenesis & Tissue Repair aims to help fill the gap in communication that exists between scientists working in different subspecialties of experimental and clinical medicine and to allow them to rapidly exchange ideas and work on common targets.

Open access

All articles published by Fibrogenesis & Tissue Repair are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in Fibrogenesis & Tissue Repair are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

Article-processing charges

Open access publishing is not without costs. Fibrogenesis & Tissue Repair therefore levies an article-processing charge of £1435/$2310/€1785 for each article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors.

Indexing services

BioMed Central is working closely with Thomson Reuters (ISI) to ensure that citation analysis of articles published in Fibrogenesis & Tissue Repair will be available.

Publication and peer review process

Letter to the Editors

Letter to the Editors articles should not discuss articles published in the journal more than 6 months previously, and should encourage discussion of the article content.

The authors of the original article will be given the opportunity to respond to any Letter to the Editors, and their response will be published alongside the Letter. For more information please contact editorial@fibrogenesis.com.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Fibrogenesis & Tissue Repair, a personalized section of the site.

Portability of peer review

In order to support efficient and thorough peer review, we aim to reduce the number of times a manuscript is re-reviewed after rejection from Fibrogenesis & Tissue Repair, thereby speeding up the publication process and reducing the burden on peer reviewers. Therefore, please note that, if a manuscript is not accepted for publication in Fibrogenesis & Tissue Repair and the authors choose to submit a revised version to another BioMed Central journal, we will pass the reviews on to the other journal's editors at the authors' request. We will reveal the reviewers' names to the handling editor for editorial purposes unless reviewers let us know when they return their report that they do not wish us to share their report with another BioMed Central journal.

Copyediting and proofs

Fibrogenesis & Tissue Repair will copyedit manuscripts before they are published.

Following the acceptance of an article, it is published in Fibrogenesis & Tissue Repair as a provisional PDF file with minimal delay (subject to formatting checks, copyediting and author verification). Fully formatted PDF and full-text (HTML) versions are made available shortly after that.

Reprints

High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints, and to enquire about further details, including fees, please contact BioMed Central's reprint service.

Supplements

Fibrogenesis & Tissue Repair will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

Any manuscript, or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Information on duplicate/overlapping publications can be found here. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.

Correspondence concerning articles published in Fibrogenesis & Tissue Repair is encouraged. A 'post a comment' feature is available on all articles published by Fibrogenesis & Tissue Repair. Comments will be moderated by the editorial office (see our Comment policy for further information) and linked to the full-text version of the article, if suitable.

Editorial standards

BioMed Central is a member of the Committee on Publication Ethics (COPE).

Data and materials release

Submission of a manuscript to Fibrogenesis & Tissue Repair implies that readily reproducible materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes.

Any 'in press' articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office.

Appeals and complaints

Authors who wish to appeal a rejection or make a complaint should, in the first instance, contact the Editor-in-Chief who will provide details of the journal's complaints procedure.

Competing interests

Fibrogenesis & Tissue Repair requires authors to declare any competing financial or other interest in relation to their work. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'.

Plagiarism detection

Fibrogenesis & Tissue Repair's publisher, BioMed Central, is a member of the CrossCheck plagiarism detection initiative. In cases of suspected plagiarism CrossCheck is available to the editors of Fibrogenesis & Tissue Repair to detect instances of overlapping and similar text in submitted manuscripts. CrossCheck is a multi-publisher initiative allowing screening of published and submitted content for originality.

Citing articles in Fibrogenesis & Tissue Repair

Articles in Fibrogenesis & Tissue Repair should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Fibrogenesis Tissue Repair [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Fibrogenesis Tissue Repair 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in Fibrogenesis & Tissue Repair?

High visibility

Fibrogenesis & Tissue Repair's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

Fibrogenesis & Tissue Repair offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles are published with their final citation immediately upon acceptance in a provisional PDF form. The article will subsequently be published in both fully browsable web form, and as a formatted PDF; the article will then be available through Fibrogenesis & Tissue Repair, BioMed Central and PubMed Central and will also be included in PubMed.

Flexibility

Online publication in Fibrogenesis & Tissue Repair gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other papers).

Promotion and press coverage

Articles published in Fibrogenesis & Tissue Repair are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Fibrogenesis & Tissue Repair's pages and on the BioMed Central homepage.

In addition, articles published in Fibrogenesis & Tissue Repair may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Fibrogenesis & Tissue Repair. A list of articles recently press-released by journals published by BioMed Central is available here.

Copyright

Authors of articles published in Fibrogenesis & Tissue Repair retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.